Related references
Note: Only part of the references are listed.National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time
Neil Mehta et al.
HEPATOLOGY (2020)
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients
Daniel J. Firl et al.
HEPATOLOGY (2020)
Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative Effort
Quirino Lai et al.
CANCERS (2020)
Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol
Jasmine Sinha et al.
HEPATOLOGY (2019)
Liver Transplantation in France
Francois Durand et al.
LIVER TRANSPLANTATION (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy
Daniel J. Firl et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease
David Goldberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Alpha-foetoprotein: further evidence to add a biological marker to refine Milan criteria
Christian Toso et al.
LIVER INTERNATIONAL (2016)
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America
Federico Pinero et al.
LIVER INTERNATIONAL (2016)
List and Liver Transplant Survival According to Waiting Time in Patients With Hepatocellular Carcinoma
P. R. Salvalaggio et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
Neehar D. Parikh et al.
LIVER TRANSPLANTATION (2015)
Time to Transplantation as a Predictor of Hepatocellular Carcinoma Recurrence After Liver Transplantation
Mariya L. Samoylova et al.
LIVER TRANSPLANTATION (2014)
Alpha-Fetoprotein Level > 1000 ng/mL as an Exclusion Criterion for Liver Transplantation in Patients With Hepatocellular Carcinoma Meeting the Milan Criteria
Bilal Hameed et al.
LIVER TRANSPLANTATION (2014)
Liver Transplantation in Latin America: The State-of-the-Art and Future Trends
Paolo R. Salvalaggio et al.
TRANSPLANTATION (2014)
Improved Waiting-List Outcomes in Argentina After the Adoption of a Model for End-Stage Liver Disease-Based Liver Allocation Policy
Nora Gabriela Cejas et al.
LIVER TRANSPLANTATION (2013)
The Use and Interpretation of Competing Risks Regression Models
James J. Dignam et al.
CLINICAL CANCER RESEARCH (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma
David Goldberg et al.
LIVER TRANSPLANTATION (2012)
MELD Exceptions and Rates of Waiting List Outcomes
A. B. Massie et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis of 15 Years of Experience
Vincenzo Mazzaferro et al.
LIVER TRANSPLANTATION (2011)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?
L. McCormack et al.
HPB (2010)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma
Gerd Otto et al.
LIVER TRANSPLANTATION (2006)
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
FY Yao et al.
LIVER TRANSPLANTATION (2005)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
